Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DJAGARIAN, ARTUR

NPI: 1598971137 · NORMAL, IL 61761 · Family Medicine Physician · NPI assigned 05/14/2007

$171K
Total Medicaid Paid
4,399
Total Claims
3,623
Beneficiaries
10
Codes Billed
2018-01
First Month
2020-06
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,228 $40K
2019 2,350 $94K
2020 821 $37K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,382 1,207 $78K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,397 1,112 $56K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 391 341 $26K
80305 1,101 848 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 27 22 $1K
80053 Comprehensive metabolic panel 24 24 $255.40
80061 Lipid panel 12 12 $75.88
85025 Blood count; complete (CBC), automated, and automated differential WBC count 12 12 $70.04
36415 Collection of venous blood by venipuncture 13 13 $8.20
80348 40 32 $0.00